By 2032, the Global IV Therapy and Vein Access Devices Market is expected to be worth $44.4 billion USD

According to a recent Future Market Insights report, the global IV Therapy and Vein Access Devices Market will generate US$ 44.4 billion while growing at a 5.6% CAGR during the forecast period. In the coming years, market growth is expected to be fueled by increasing government support. The industry is expected to generate $25.8 billion USD in 2022.

Attributes

Details

Global IV Therapy and Vein Access Devices Market CAGR (2022-2032)

5.6%

Global IV Therapy and Vein Access Devices Market (2032)

US$ 44.4 Billion

Global IV Therapy and Vein Access Devices Market Attraction

The rising number of intravenous (IV) drug approvals and increasing technological advancements in intravenous therapy (IV) and vein access are expected to drive the market in the forecast period.

Increased healthcare spending, increased awareness of healthcare procedures, and an increase in the number of specialty clinics and ambulatory centres will all contribute to the market's future growth.

The medical administration segment, according to the research, is expected to provide lucrative opportunities for the global IV therapy and vein access devices market. Several developing countries are making significant budget changes, opening up lucrative opportunities for market participants.

Key Takeaways from the Market Study

  • Intravenous catheters are expected to grow at a 5.5% CAGR by 2032.
  • The medical administration segment is expected to grow at a 5.6% annual rate during the forecast period.
  • From 2022 to 2032, the US market will be worth $15.9 billion, with a 5.4% CAGR.
  • China's market will acquire US$ 3.2 billion, expanding at a 4.9% annual rate during the assessment period.

Competitive Landscape

Eminent players of the global IV Therapy and Vein Access Devices Market include Becton, Dickinson and Company, B. Braun Holding Gmbh & Co. Kg, Terumo Medical Corporation, Teleflex Medical Inc., and Medtronic Inc. among others.  Recent key developments among players include:

  • In February 2022, BD (Becton, Dickinson and Company) announced the acquisition of Cytognos, a privately held company based in Salamanca, Spain that specialises in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection, and immune monitoring research for blood diseases.
  • Teleflex will release the Arrow® ErgoPack® Complete Multi-LumenAccessCatheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) System in January 2021. High-flow Arrow® MAC Catheters are designed to meet the needs of a wide range of patients, from trauma to cardiac, and provide broad-spectrum antimicrobial protection against gram-positive and gram-negative bacteria and fungi, which are the primary infectious pathogens responsible for CLABSI.

Get More Details of Report@ https://www.futuremarketinsights.com/reports/iv-therapy-and-vein-access-devices-market

Comments

Post a Comment

Popular posts from this blog

Portable Oxygen Concentrators Market | Innovative and Technological Advancement

Image
The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards ...
Read more

Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032

Image
During the forecast period 2022 to 2032, the global pediatric clinical trials market  is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the onc...
Read more

Helicobacter Pylori Infections Treatment Market Research and Analysis 2023 to 2033

Image
The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor sanitation, a large population, and poor personal hygiene. One of the factors influencing the Helicobacter pylori diagnostics market's growth is increased awareness of H. pylori infections in the cohort. Antibiotic availability and affordability, as well as quicker processing times, will boost antibiotic use and the need for pre and post-surveillance tests. Furthermore, rising H. pylori infection rates, the need for early symptom diagnosis, and technological advances in diagnostic methods are expected to fuel overall growth over the forecast period. The key drivers of the industry are the increasing prevalence of communicable diseases and rising pub...
Read more